SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report
Introduction: Investigation on virus-host interaction may provide new clues for antitumor immunotherapy. Case Presentation: In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest t...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2024-11-01
|
| Series: | Case Reports in Oncology |
| Subjects: | |
| Online Access: | https://beta.karger.com/Article/FullText/541964 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850191262506811392 |
|---|---|
| author | Yan Xiao Jinwei Wang Kai Yang Meiling Jiang Bo Zhang |
| author_facet | Yan Xiao Jinwei Wang Kai Yang Meiling Jiang Bo Zhang |
| author_sort | Yan Xiao |
| collection | DOAJ |
| description | Introduction: Investigation on virus-host interaction may provide new clues for antitumor immunotherapy. Case Presentation: In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest that virus induced cross-reactivity against tumor account for the remission. Conclusion: Mapping epitope characteristics on B cell non-Hodgkin lymphoma antigen and on SARS-COV-2 antigen may provide much needed information for antigen based antitumor immune therapy in the future. |
| format | Article |
| id | doaj-art-9cdd02a274d047239a5ac0b38c1c822a |
| institution | OA Journals |
| issn | 1662-6575 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Karger Publishers |
| record_format | Article |
| series | Case Reports in Oncology |
| spelling | doaj-art-9cdd02a274d047239a5ac0b38c1c822a2025-08-20T02:14:58ZengKarger PublishersCase Reports in Oncology1662-65752024-11-011711273127610.1159/000541964541964SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case ReportYan Xiao0Jinwei Wang1Kai Yang2Meiling Jiang3Bo Zhang4Respiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, ChinaRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, ChinaRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, ChinaRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, ChinaRespiratory Infection and Critical Disease Diagnosis and Treatment, Beijing Gobroad Boren Hospital, Beijing, ChinaIntroduction: Investigation on virus-host interaction may provide new clues for antitumor immunotherapy. Case Presentation: In this case report, we describe an unusual case of B-cell non-Hodgkin lymphoma in an aged woman who recovered following SARS-COV-2 infection. We discuss the case and suggest that virus induced cross-reactivity against tumor account for the remission. Conclusion: Mapping epitope characteristics on B cell non-Hodgkin lymphoma antigen and on SARS-COV-2 antigen may provide much needed information for antigen based antitumor immune therapy in the future.https://beta.karger.com/Article/FullText/541964sars-cov-2b-cell non-hodgkin lymphomaimmune cross-reactivitytumor remission |
| spellingShingle | Yan Xiao Jinwei Wang Kai Yang Meiling Jiang Bo Zhang SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report Case Reports in Oncology sars-cov-2 b-cell non-hodgkin lymphoma immune cross-reactivity tumor remission |
| title | SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report |
| title_full | SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report |
| title_fullStr | SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report |
| title_full_unstemmed | SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report |
| title_short | SARS-CoV-2-Induced Remission of Chemotherapy Resistance B-Cell Non-Hodgkin Lymphoma: A Case Report |
| title_sort | sars cov 2 induced remission of chemotherapy resistance b cell non hodgkin lymphoma a case report |
| topic | sars-cov-2 b-cell non-hodgkin lymphoma immune cross-reactivity tumor remission |
| url | https://beta.karger.com/Article/FullText/541964 |
| work_keys_str_mv | AT yanxiao sarscov2inducedremissionofchemotherapyresistancebcellnonhodgkinlymphomaacasereport AT jinweiwang sarscov2inducedremissionofchemotherapyresistancebcellnonhodgkinlymphomaacasereport AT kaiyang sarscov2inducedremissionofchemotherapyresistancebcellnonhodgkinlymphomaacasereport AT meilingjiang sarscov2inducedremissionofchemotherapyresistancebcellnonhodgkinlymphomaacasereport AT bozhang sarscov2inducedremissionofchemotherapyresistancebcellnonhodgkinlymphomaacasereport |